Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$7.0 - $14.77 $78,974 - $166,635
11,282 New
11,282 $164,000
Q2 2022

Aug 03, 2022

SELL
$6.85 - $8.87 $15,734 - $20,374
-2,297 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$6.3 - $10.86 $49,114 - $84,664
-7,796 Reduced 77.24%
2,297 $18,000
Q4 2021

Feb 23, 2022

BUY
$9.44 - $12.24 $95,277 - $123,538
10,093 New
10,093 $109,000

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.